atenolol has been researched along with Temporomandibular Joint Disorders in 2 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Temporomandibular Joint Disorders: A variety of conditions affecting the anatomic and functional characteristics of the temporomandibular joint. Factors contributing to the complexity of temporomandibular diseases are its relation to dentition and mastication and the symptomatic effects in other areas which account for referred pain to the joint and the difficulties in applying traditional diagnostic procedures to temporomandibular joint pathology where tissue is rarely obtained and x-rays are often inadequate or nonspecific. Common diseases are developmental abnormalities, trauma, subluxation, luxation, arthritis, and neoplasia. (From Thoma's Oral Pathology, 6th ed, pp577-600)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fávaro-Moreira, NC | 1 |
| Okoti, LW | 1 |
| Furini, R | 1 |
| Tambeli, CH | 2 |
| Oliveira-Fusaro, MC | 1 |
| Clemente-Napimoga, JT | 1 |
| Teixeira, JM | 1 |
| Torres-Chávez, KE | 1 |
| Parada, CA | 1 |
2 other studies available for atenolol and Temporomandibular Joint Disorders
| Article | Year |
|---|---|
Gonadal hormones modulate the responsiveness to local β-blocker-induced antinociception in the temporomandibular joint of male and female rats.
Topics: Adrenergic beta-3 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Female; Gona | 2015 |
5-HT induces temporomandibular joint nociception in rats through the local release of inflammatory mediators and activation of local β adrenoceptors.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents, Non-Steroi | 2012 |